|

BSI-082 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Lei Zheng1

Indications

  • Metastatic Solid Tumor1
  • Advanced Solid Tumor1
  • Solid Tumor1
  • Cancer1

San Antonio, Texas1 trial

Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

University of Texas Health Science Center at San Antonio

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.